ulrich medical USA, Inc., has announced the U.S. market release of its tezo® spine implants for multiple surgical approaches to lumbosacral interbody fusion.
In a newly issued press release, ulrich medical points to the unique feature of the tezo PLIF, TLIF and ALIF products, namely that they maintain a porous structure on the inner surfaces of the implants that promotes integration of bone for enhanced fusion, as well as retroserrated toothing on the caudal and cranial surfaces of the implants that provide for very effective primary stability. The implants are available in numerous heights and angles, which allow for precise, intraoperative anatomical adaptation. Depending upon surgical technique preference, the tezo devices are available from a 7mm height to a 34mm width in multiple lordotic angles.
“We are experiencing a segmental market shift in the degenerative spine sector: A growing number of U.S. surgeons are switching back to interbody devices that are made from titanium materials versus polyetheretherketone (PEEK),” said Erika Laskey, Vice President of Sales and Marketing, ulrich medical USA. “Titanium implants have a long and proven clinical history versus plastic implant technologies. And for many of our U.S. surgeons, the originally perceived imaging benefits of PEEK material implants are proving to be less important than the osseointegration qualities and overall implant strength and stability that titanium devices afford.”
“We believe that every patient deserves the best possible solution for their individual clinical needs, and there are benefits to both titanium and PEEK interbody technologies,” Laskey continued. “As a result, we will continue to offer our wide range of pezo interbody implants (PEEK) in addition to the new tezo implants, which will give surgeons access to one of the broadest product portfolios in both PEEK and titanium interbody devices available in the U.S. spine market today.”
Source: ulrich medical USA, Inc., PR Newswire